Concepedia

Concept

rheumatology

Parents

Children

64.7K

Publications

3.2M

Citations

187.3K

Authors

14.3K

Institutions

Steroid-Driven Rheumatoid Arthritis Criteria

1931 - 1960

Rheumatoid arthritis during 1931-1960 is characterized by a systemic disease conception, where vascular pathology and non-articular tissue involvement broaden the research agenda beyond joints. Immunoserology and the search for serologic biomarkers become central to diagnosis and prognosis, informing laboratory approaches and patient stratification. Endocrine modulation and early corticosteroid therapy redefine management, while attention to infectious triggers and preventive strategies fosters a preventive paradigm; pathology reveals lesion patterns in muscle, spine, and other tissues that extend disease biology beyond synovitis.

Systemic organ involvement and vascular pathology unify rheumatoid arthritis across organ systems, highlighting arteritis, vascular lesions, and cardiac manifestations as core disease processes [4], [5], [6], [7], [12].

Immunoserology reveals autoantibody-like responses and serologic biomarkers with multiple hemagglutination studies and serum protein analyses shaping autoimmune understanding in RA [10], [11], [14], [17], [19].

Endocrine modulation and therapeutic criteria influenced early RA management, integrating adrenal cortex hormone effects with guideline-like treatment criteria to guide responses [3], [8].

Infectious factors and preventive strategies anchor a preventive paradigm, linking streptococcal infections to rheumatic activity and supporting prophylaxis to reduce recurrences [9], [13], [16].

Pathology-focused lesion patterns illuminate disease biology, from arteritis of striated muscle to vertebral nodules and febrile rheumatism tissue changes, highlighting non-joint pathology [1], [15], [20].

Immunoserology-Driven Rheumatology

1961 - 1970

Immunopathology of Inflammatory Arthritis

1971 - 1977

Immunogenetic Autoimmunity

1978 - 1984

Immunobiology-Driven Arthritis Therapies

1985 - 1999

Targeted Biologic Immunotherapy

2000 - 2006

IL-6–centered therapeutics and classification

2007 - 2013

Mechanistic Treat-to-Target

2014 - 2023